87 FR 141 pgs. 44121-44122 - Proposed Data Collection Submitted for Public Comment and Recommendations
Type: NOTICEVolume: 87Number: 141Pages: 44121 - 44122
Pages: 44121, 44122Docket number: [60Day-22-1282; Docket No. CDC-2022-0092]
FR document: [FR Doc. 2022-15767 Filed 7-22-22; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version: PDF Version
[top]
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-22-1282; Docket No. CDC-2022-0092]
Proposed Data Collection Submitted for Public Comment and Recommendations
AGENCY:
Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).
ACTION:
Notice with comment period.
SUMMARY:
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Improving Performance Measurement and Monitoring by CDC Programs: The Performance Measures Project. CDC is requesting approval for a revision to the previously approved project to work with selected CDC programs to provide tools, templates and technical assistance to develop and implement performance measures for CDC funded public health initiatives.
DATES:
CDC must receive written comments on or before September 23, 2022.
ADDRESSES:
You may submit comments, identified by Docket No. CDC-2022-0092 by either of the following methods:
• Federal eRulemaking Portal: www.regulations.gov. Follow the instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking portal (www.regulations.gov) or by U.S. mail to the address listed above.
FOR FURTHER INFORMATION CONTACT:
To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION:
Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to be collected;
4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses; and
5. Assess information collection costs.
Proposed Project
Improving Performance Measurement and Monitoring by CDC Programs: The Performance Measures Project (OMB Control No. 0920-1282, Exp. 01/31/2023)-Revision-Office of the Associate Director for Policy and Strategy (OADPS), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
[top] Each year, approximately 75% of the CDC's congressionally appropriated funding goes to extramural organizations, including state and local partners, via contracts, grants, and, most commonly, cooperative agreements. The
CDC programs develop logic models for each NOFO, describing the key programmatic strategies and activities and the short/medium/long-term outcomes funded recipients are expected to achieve during their period of performance. Programs develop performance measures customized to a NOFO-specific public health initiative to assess actions prescribed by the logic model with the immediate goal of monitoring progress and the long-term goal of improving performance.
Monitoring and reporting of program performance is required of any non-federal entity receiving federal funds under 45 CFR 75.342 which states; "the non-Federal entity must monitor its activities under Federal awards to assure compliance with applicable Federal requirements and performance expectations are being achieved". Under this requested approval, CDC programs customize a sample "Performance Measure Technical Specification Instrument" and a sample "Performance Measure Reporting Instrument" to measure, at the local level, the desired public health outcomes of a particular public health initiative, in compliance with the Paperwork Reduction Act (PRA). Individual collection requests submitted under this Generic approval will include the tailored forms and a supplementary template. CDC programs developing new, non-research NOFOs are eligible to participate.
Currently three CDC programs have received OMB approval to collect performance measure data using the 0920-1282 Generic Information Collection. Two additional programs are in final CDC clearance for submitting their Generic ICR (GenIC) requests and three programs are actively developing applications. As CDC programs begin to normalize operations following the COVID-19 pandemic, numerous other CDC programs have showed strong interest in participating in the Performance Measures Project (PMP) when: (1) they develop new NOFOs or; (2) transition current performance measure data collection from the HHS Public Health Emergency (PHE) PRA waiver for Coronavirus Disease 2019 [COVID-19] to the PMP GenIC for ongoing performance data collection. This revision is requested to allow participating CDC programs to continue performance measure data collection through the remaining approval period and for additional programs to use the GenIC for future performance measure data collection.
This revision reflects expanded technical assistance that the Program Performance and Evaluation Office (PPEO) provides to CDC programs. CDC program eligibility to participate in PMP will be expanded as follows:
(1) Given the recent increase in grants and other funding mechanisms used at CDC to enhance programmatic flexibility, PMP eligibility will expand to include all available funding mechanisms for eligible programs.
(2) PPEO is providing increasing technical assistance to international programs. Eligibility will expand to include both domestic and international programs.
(3) Many CDC programs are operating under the 21st Century Cures Act PHE PRA COVID-19 Emergency Waiver. This PHE PRA Waiver is likely to be terminated in 2022. PMP will prioritize transitioning CDC program performance measure data collection from the PHE PRA Waiver to PMP.
(4) Some CDC programs are developing common performance metrics across multiple public health initiatives. PMP will prioritize cross-NOFO collaboration with these programs to increase efficiency.
(5) As programs transition back to normal function after the COVID-19 pandemic, there has been increased interest in PMP. The revision will increase the number of programs that may participate from 25 Programs to 40, resulting in an increase of estimated annual burden hours from 35,000 to 56,000.
CDC requests OMB approval for an estimated 56,000 annual burden hours. Participation of respondents is voluntary. There are no costs to respondents other than their time.
| Type of respondents | Form name | Number of respondents | Number of responses per respondent | Average burden per response (in hours) | Total burden (in hours) |
|---|---|---|---|---|---|
| Recipients of CDC funds for public health initiatives | Performance Measures Project Information Collection Tool | 1400 | 1 | 40 | 56,000 |
| Total | 56,000 |
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention.
[FR Doc. 2022-15767 Filed 7-22-22; 8:45 am]
BILLING CODE 4163-18-P